New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
06:33 EDTFMI, CLVSFoundation Medicine and Clovis Oncology partner for cancer diagnostic
Foundation Medicine (FMI) and Clovis Oncology (CLVS) are expanding their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval companion diagnostic test. This test is designed for use by physicians to identify patients most likely to respond to rucaparib, Clovis’ poly polymerase inhibitor currently the subject of Phase 2 and Phase 3 clinical trials in patients with ovarian cancer. This companion diagnostic is being developed in parallel with the clinical development of rucaparib to facilitate an FDA submission of the PMA for the companion diagnostic concurrent with the New Drug Application for rucaparib.
News For FMI;CLVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
07:27 EDTFMIFoundation Medicine has a conference call hosted by JPMorgan
Subscribe for More Information
May 18, 2015
07:27 EDTCLVSClovis price target raised to $125 from $90 at Stifel
Subscribe for More Information
May 15, 2015
10:01 EDTCLVSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:04 EDTCLVSClovis downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
May 14, 2015
16:19 EDTCLVSOn The Fly: Top stock stories for Thursday
Subscribe for More Information
09:22 EDTCLVSLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
05:52 EDTCLVSMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:23 EDTCLVSClovis announces ASCO presentations including TIGER-X study update
Subscribe for More Information
07:28 EDTFMIFoundation Medicine price target lowered to $48-52 from $60-65 at Wells Fargo
Subscribe for More Information
07:06 EDTFMIFoundation Medicine announces new data on FoundationOne assay
Subscribe for More Information
May 12, 2015
08:20 EDTFMIFoundation Medicine weakness creates buying opportunity, says JMP Securities
Subscribe for More Information
08:08 EDTCLVSClovis has a conference call hosted by JPMorgan
Subscribe for More Information
May 11, 2015
18:29 EDTFMIAffordable Care Act guidance says insurers must cover BRCA1, BRCA2 testing
The United States Department of Labor issued updated Affordable Care Act guidance, which mandates that health insurers must cover testing for breast and ovarian cancer through analysis of the BRCA1 and BRCA2 genes. Myriad (MYGN), Foundation Medicine (FMI), and Genomic Health (GHDX) compete in the genetic testing space. Reference Link
16:03 EDTFMIFoundation Medicine reports 7,854 clinical tests in Q1, up 67% y/y
Subscribe for More Information
16:02 EDTFMIFoundation Medicine sees FY15 revenue $105M-$115M, consensus $108.73M
Subscribe for More Information
16:01 EDTFMIFoundation Medicine reports Q1 EPS (59c), consensus (53c)
Reports Q1 revenue $19.3M, consensus $20.98M.
15:00 EDTFMINotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use